Seer Q4 2021 rev $3.1M, FY rev $6.6M; guides FY2022 rev $14-16M

Seer, Inc.

2021-FY EPS reported -$1.17 revenue$6,617,000

Q4 revenue $3.1M (up from $336K YoY); net loss $19.7M vs $12.9M.
Full-year 2021 revenue $6.6M vs $656K; net loss $71.2M vs $32.8M.
Gross margin 47% in Q4, 52% for full year; cash+investments $493.3M.
Shipped 17 instruments through year-end 2021; broad commercial release of Proteograph commenced.
2022 revenue guidance $14-16M; expects to increase investments in commercial, ops, and R&D.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.